ROIV vs TDG · rev $8.3M vs P/E 41, rev $8.83B
Roivant Sciences Ltd (ROIV) versus Transdigm Group Incorporated (TDG) — a side-by-side from cached financials, not a winner call.
Roivant Sciences Ltd (ROIV) is a biotechnology company listed on US.
Transdigm Group Incorporated (TDG) is a aerospace & defense company listed on NYSE.
Latest reported ROIV revenue for 2026-03-31 was $8.3M. Net income was -$299.8M. Revenue was down 71.6% from 2025-03-31 to 2026-03-31. ROIV currently screens at market cap $7.47B.
Latest reported TDG revenue for 2025-09-30 was $8.83B. Net income was $2.07B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
ROIV currently screens at market cap $7.47B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
Not investment advice. Open the ROIV and TDG stock pages for the full models.
Not investment advice.